Dr. Reddys Laboratories reply to clarification sought by the exchange

22 Aug 2015 Evaluate

The Exchange had sought clarification from Dr Reddys Laboratories with respect to news appearing on Business Standard on August 21, 2015 titled ‘DRL recalls dementia capsules in US’. Dr Reddys Laboratories replied stating that in this regard, they would like to state that Dr. Reddys have recalled one batch of USP 1.5mg Rivastigmine Tartarate capsule from US market. This is a batch specific voluntary recall in conformance with our quality assurance norms practiced. The business impact from this will not be substantial.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1208.45 -15.85 (-1.29%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×